These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32659427)

  • 1. DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents.
    Ma Y; Chai N; Jiang Q; Chang Z; Chai Y; Li X; Sun H; Hou J; Linghu E
    Pharmacol Res; 2020 Oct; 160():105071. PubMed ID: 32659427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients.
    Wang JH; Zeng Z; Sun J; Chen Y; Gao X
    Pharmacol Res; 2021 Nov; 173():105869. PubMed ID: 34481973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
    Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
    BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes.
    Azizi M; Fard-Esfahani P; Mahmoodzadeh H; Fazeli MS; Azadmanesh K; Zeinali S; Teimoori-Toolabi L
    Epigenomics; 2017 Aug; 9(8):1059-1075. PubMed ID: 28758420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal.
    Pan Y; Li K; Tao X; Zhao Y; Chen Q; Li N; Liu J; Go VLW; Guo J; Gao G; Xiao GG
    Pancreas; 2021 Oct; 50(9):1260-1266. PubMed ID: 34860809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of the miR‑29b‑3p promoter contributes to angiogenesis, invasion, and migration in pancreatic cancer.
    Wang L; Mu N; Qu N
    Oncol Rep; 2021 Jan; 45(1):65-72. PubMed ID: 33416135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression.
    Xie VK; Li Z; Yan Y; Jia Z; Zuo X; Ju Z; Wang J; Du J; Xie D; Xie K; Wei D
    Clin Cancer Res; 2017 Sep; 23(18):5585-5597. PubMed ID: 28659310
    [No Abstract]   [Full Text] [Related]  

  • 8. The interaction between miR‑148a and DNMT1 suppresses cell migration and invasion by reactivating tumor suppressor genes in pancreatic cancer.
    Hong L; Sun G; Peng L; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
    Oncol Rep; 2018 Nov; 40(5):2916-2925. PubMed ID: 30226601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,6-Dihydroxyflavone Suppresses Breast Carcinogenesis by Epigenetically Regulating miR-34a and miR-21.
    Peng X; Chang H; Gu Y; Chen J; Yi L; Xie Q; Zhu J; Zhang Q; Mi M
    Cancer Prev Res (Phila); 2015 Jun; 8(6):509-17. PubMed ID: 25784176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
    Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
    Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
    Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
    Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
    J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
    Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
    Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer.
    Xu K; Chen B; Li B; Li C; Zhang Y; Jiang N; Lang B
    Aging (Albany NY); 2020 Nov; 12(23):23668-23683. PubMed ID: 33221743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy.
    Li H; Yu G; Shi R; Lang B; Chen X; Xia D; Xiao H; Guo X; Guan W; Ye Z; Xiao W; Xu H
    Mol Cancer; 2014 Jan; 13():8. PubMed ID: 24423412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy.
    Zhan Q; Fang Y; Deng X; Chen H; Jin J; Lu X; Peng C; Li H; Shen B
    Cancer Invest; 2015; 33(7):267-75. PubMed ID: 25950085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
    Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
    Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.
    Li CH; Xiao Z; Tong JH; To KF; Fang X; Cheng AS; Chen Y
    Int J Cancer; 2017 Jan; 140(1):120-129. PubMed ID: 27594424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications.
    Wong KK
    Cell Oncol (Dordr); 2020 Oct; 43(5):779-792. PubMed ID: 32504382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.